[
    {
        "question": "List Cdk targets that are dephosphorylated during cytokinesis",
        "answer": "1. CDK1/Cyclin B complex: CDK1 is a key regulator of cell division and is activated by phosphorylation. However, during cytokinesis, CDK1 needs to be dephosphorylated to control the exit from mitosis. This dephosphorylation is mediated by phosphatase enzymes such as CDC25.\n2. Myosin: Myosin is a motor protein that plays a crucial role in cytokinesis by generating contractile forces to drive cell furrowing. Phosphorylation of myosin by CDK1 inhibits its activity. Therefore, during cytokinesis, myosin needs to be dephosphorylated to become activated and promote contractile ring contraction. Phosphatases such as PP1 and PP2A mediate the dephosphorylation of myosin.\n3. Ect2: Ect2 is a Rho family guanine nucleotide exchange factor (GEF) that activates the small GTPase RhoA during cytokinesis. Phosphorylation of Ect2 by CDK1 inhibits its activity. To enable RhoA activation and subsequent contractile ring assembly, Ect2 needs to be dephosphorylated. The phosphatase PP1 has been implicated in the dephosphorylation of Ect2.\n4. Anillin: Anillin is a cytoskeletal protein that binds to the actin cytoskeleton and plays a role in cytokinesis. Phosphorylation of anillin by CDK1 regulates its localization and interaction with other cytokinesis proteins. During cytokinesis, anillin needs to be dephosphorylated to promote furrow ingression. Phosphatases such as PP1 and PP2A are involved in the dephosphorylation of anillin.\n5. Cofilin: Cofilin is an actin-binding protein that regulates actin dynamics during cytokinesis. Phosphorylation of cofilin by CDK1 inhibits its actin-depolymerizing activity. Dephosphorylation of cofilin by phosphatases such as chronophin and slingshot is required for actin remodeling and furrow ingression during cytokinesis.",
        "judge": 1
    },
    {
        "question": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
        "answer": "One siRNA based drug currently in clinical trials for the treatment of pancreatic cancer is \"AZD 9150\".",
        "judge": 1
    },
    {
        "question": "Describe Achenbach’s syndrome.",
        "answer": "Achenbach syndrome, also known as arterial calcification of infancy or infantile calcification, is a rare genetic disorder characterized by the calcification of arterial walls in infants. This condition primarily affects medium to large-sized arteries in the body.\nThe exact cause of Achenbach syndrome is not fully understood but it is believed to be a result of a defect in the metabolism of calcium and phosphate, leading to abnormal deposition of calcium in the arterial walls. This can cause the arteries to become rigid and narrowed, leading to decreased blood flow to certain organs.\nSymptoms of Achenbach syndrome typically appear shortly after birth or during early infancy. The most common symptom is ischemic necrosis, which occurs when an organ or tissue does not receive enough oxygen and nutrients due to decreased blood flow. This can lead to tissue damage and the formation of ulcers or necrotic lesions on the skin, especially on the fingers, toes, or other extremities. Other symptoms may include pain, swelling, and limited movement in the affected areas.\nDiagnosis of Achenbach syndrome involves a combination of clinical examination, imaging tests, and genetic testing. X-rays, ultrasound, or computed tomography (CT) scans can help identify calcifications in the arterial walls. Genetic testing can help confirm the presence of specific gene mutations associated with Achenbach syndrome.\nThere is currently no cure for Achenbach syndrome, and treatment mainly focuses on managing the symptoms and preventing complications. This may include the use of medications to improve blood flow, surgical interventions to remove calcifications or restore blood flow, and wound care to manage ulcers or necrotic lesions. Physical therapy may also be recommended to improve mobility and prevent further complications.\nAchenbach syndrome has a variable prognosis, as it can range from mild cases with minimal symptoms to severe cases with significant complications. The long-term outlook depends on the extent and location of calcifications, as well as individual factors. Early diagnosis and appropriate treatment can help improve outcomes and quality of life for individuals with Achenbach syndrome.",
        "judge": 1
    },
    {
        "question": "What does a high theta mean for an option position?",
        "answer": "A high theta for an option position means that the option's time decay is significant. Theta is a Greek letter used to represent the measure of time decay in options. It indicates how much an option's price will decrease with the passage of time, assuming all other factors remain constant.\nWhen an option has a high positive theta, it means that its time decay is occurring rapidly. This suggests that the option is losing value at a quick pace as time passes, and if the underlying asset's price remains stagnant, the option's price will decrease. This can be particularly important for options traders who rely on time decay as a strategy, such as sellers of options.\nOn the other hand, if an option has a high negative theta, it means that time decay is working against the option holder. This negative theta implies that the option will lose value quickly with the passage of time. This scenario is generally disadvantageous for option buyers who want the option's price to increase in line with the underlying asset.\nIt is important for options traders to consider theta when assessing the potential profitability and risk of their option positions, as it can greatly impact the value and performance of the options over time.",
        "judge": 0
    },
    {
        "question": "What is particular about the mouse Fxy gene's chromosomal position?",
        "answer": "The mouse Fxy gene is located on the X chromosome. This chromosomal position is significant because it makes the Fxy gene subject to X chromosome inactivation in females. X chromosome inactivation is a process in female mammals where one of the two X chromosomes is randomly inactivated in each cell to achieve dosage compensation between males and females. As a result, only one copy of the Fxy gene is active in female cells, while both copies are active in male cells. This has implications for the expression of the Fxy gene and its associated functions.",
        "judge": 1
    },
    {
        "question": "How do I get rid of worthless penny stocks if there is no volume (so market/limit orders don't work) and my broker won't buy them from me?",
        "answer": "If you are unable to sell your penny stocks due to lack of volume and your broker is unwilling to buy them from you, there are a few options you can consider:\n1. Contact your broker: Reach out to your broker and explain the situation. Ask them if there are any alternatives or if they can provide any guidance on how to handle the situation. They may have specific procedures or suggestions for illiquid securities.\n2. Seek assistance from a different broker: If your current broker is unable or unwilling to assist you, consider contacting other brokerage firms to see if they have any solutions or recommendations for selling these penny stocks.\n3. Use offline methods: In certain cases, it may be possible to find private buyers for your penny stocks through various online forums, social media groups, or even local investment clubs. However, exercise caution and ensure you understand the risks involved when trying to sell securities through unofficial channels.\n4. Donation or tax write-off: If the penny stocks have become essentially worthless and you have exhausted all options, it might be worth considering donating them to a nonprofit organization. You can potentially benefit from a tax write-off for the loss incurred.\n5. Consult with a financial advisor or attorney: Seeking advice from a financial advisor or securities attorney can provide you with expert guidance tailored to your specific situation. They can help explore additional options and potentially assist in resolving the issue.\nRemember, the handling of illiquid securities can be complex, and it's important to navigate this process with caution, seeking professional advice when needed.",
        "judge": 0
    },
    {
        "question": "Does the expense ratio of a fund-of-funds include the expense ratios of its holdings?",
        "answer": "Yes, the expense ratio of a fund-of-funds includes the expense ratios of its underlying holdings. A fund-of-funds is a mutual fund or exchange-traded fund that invests in other mutual funds or ETFs, known as the underlying holdings. The expense ratio of the fund-of-funds represents the total cost of managing the fund, which includes management fees, administrative expenses, operating expenses, and any other costs associated with running the fund. This expense ratio is calculated based on the net asset value (NAV) of the fund and is expressed as a percentage of the fund's average assets under management. The expense ratio includes the expenses of the underlying funds, meaning that investors pay for the expenses of both the fund-of-funds and the underlying funds it holds.",
        "judge": 0
    },
    {
        "question": "“International credit report” for French nationals?",
        "answer": "As of my knowledge in August 2021, there is no officially recognized \"international credit report\" specifically for French nationals. Credit reports are typically country-specific and managed by the respective credit bureaus or agencies within each country. In France, the main credit bureau is the National Bank of France (Banque de France) which maintains credit information on individuals and businesses within the country.\nHowever, when French nationals immigrate or move abroad, their credit history in France may not be directly transferable or accessible to foreign lenders. In such cases, individuals may need to establish new credit histories in their new country of residence. Some international credit bureaus or agencies, such as Experian or Equifax, may offer services for individuals obtaining credit in multiple countries, but it's important to note that these are typically not official or universally recognized reports.\nIf you are a French national and plan to move or establish credit outside of France, it is recommended to research the credit reporting systems and credit bureaus in the specific country you are moving to, as their requirements and reporting mechanisms may differ. It can be helpful to provide proof of your credit history from France to the new lenders, but ultimately, they may still evaluate your creditworthiness based on local credit assessment criteria.",
        "judge": 0
    },
    {
        "question": "Is SIPC coverage on cash as strong as FDIC?",
        "answer": "No, SIPC (Securities Investor Protection Corporation) coverage on cash is not as strong as FDIC (Federal Deposit Insurance Corporation) coverage. The SIPC is a nonprofit membership corporation that provides limited protection to investors against the loss of cash and securities held by a brokerage firm in the event of its bankruptcy or insolvency. SIPC coverage is limited to $250,000 in cash, of which $100,000 can be received in cash. \nOn the other hand, the FDIC is a federal agency that provides deposit insurance to banks and savings associations. FDIC coverage is much stronger and provides up to $250,000 per depositor, per bank, for each account ownership category. This means that if an individual has multiple accounts with different ownership categories (such as individual, joint, or retirement accounts), each account is separately insured up to the $250,000 limit.",
        "judge": 0
    },
    {
        "question": "Which is the database of somatic mutations in normal cells?",
        "answer": "The database of somatic mutations in normal cells is known as The Cancer Genome Atlas (TCGA). It is a comprehensive database that catalogues genomic alterations, including somatic mutations, in various cancer types. TCGA provides valuable information about the genetic changes occurring in both tumor and normal cells, facilitating the understanding of cancer biology and the development of targeted therapies.",
        "judge": 1
    },
    {
        "question": "Is recursive splicing more common in short introns?",
        "answer": "Yes, recursive splicing is more common in short introns. Recursive splicing is a phenomenon where an intron is spliced into multiple smaller pieces before being completely removed from the pre-mRNA. This process involves the iterative cleavage and ligation of the intron, resulting in multiple rounds of splicing. Short introns provide a greater opportunity for recursive splicing because they can be more easily divided into smaller pieces. In contrast, longer introns may be too large to be efficiently processed through recursive splicing.",
        "judge": 1
    },
    {
        "question": "How truthful is the statement that \"Tuberculosis-induced granulomas express different immune system protein signatures than the surrounding tissue.\"? Present a series of factual points about the statement.",
        "answer": "1. The statement is true and backed by scientific evidence. Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis, which primarily affects the lungs. When M. tuberculosis enters the body, it triggers an immune response leading to the formation of granulomas.\n2. Granulomas are organized structures consisting of immune cells, such as macrophages, lymphocytes, and dendritic cells, surrounding infected cells or bacteria. They form as an attempt to contain the infection and prevent its spread.\n3. The composition and function of immune cells within the granulomas differ from those in the surrounding healthy tissue. Various studies have identified distinct protein signatures or expression profiles within TB-induced granulomas.\n4. One study published in the journal PLOS Pathogens found that different immune system proteins, such as CCL2, CXCL1, and TNF, were significantly upregulated in TB granulomas compared to nearby lung tissue. These proteins are involved in inflammation, immune cell recruitment, and destruction of infected cells.\n5. Another study published in The Journal of Immunology observed that TB granulomas showed increased expression of proteins associated with T-cell immune responses, including interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and various chemokines involved in attracting immune cells to the site of infection.\n6. Furthermore, the International Journal of Mycobacteriology reported that certain proteins related to granuloma formation and maintenance, such as matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), exhibited specific expression patterns within TB-induced granulomas.\n7. These protein signatures within TB granulomas are crucial for understanding the underlying immune response to tuberculosis and can potentially be used as biomarkers for diagnosing and monitoring the disease.\nIn summary, available scientific evidence supports the statement that tuberculosis-induced granulomas express different immune system protein signatures than the surrounding tissue. The unique protein expression patterns are vital in studying the immune response to TB and offer potential avenues for diagnostic and therapeutic advancements.",
        "judge": 0
    },
    {
        "question": "Which web-based pedigree editors are available?",
        "answer": "There are several web-based pedigree editors available, including:\n1. Progeny: Progeny is a comprehensive pedigree editor that allows users to create, edit, and analyze pedigrees. It offers various features such as customizable pedigree symbols, color-coding, and the ability to add medical information to individuals. Progeny also offers integrated genetic and statistical analysis capabilities.\n2. Pedigree Editor: Pedigree Editor is a user-friendly web-based tool that enables users to create and edit pedigrees for genetic research or clinical purposes. It offers a simple interface with drag-and-drop functionality and allows users to add different types of information to individuals, such as phenotype, genotype, and medical history.\n3. Breeders Assistant: Breeders Assistant is a web-based pedigree editor specifically designed for animal breeders. It offers a range of features tailored to the needs of breeders, including the ability to track and manage breeding lines, view genetic data, and generate reports and pedigrees.\n4. PedigreeXP: PedigreeXP is a web-based pedigree editor that offers advanced features for genetics research and breeding programs. It allows users to create pedigrees with complex relationships, incorporate genetic markers, and perform advanced analysis such as inbreeding coefficients and kinship calculations.\n5. PedEasy: PedEasy is a free, web-based pedigree editor developed by the National Human Genome Research Institute. It is designed for creating and editing pedigrees for genetic studies and offers features such as standard pedigree symbols, color-coding, and the ability to add detailed medical information.\nThese are just a few examples of the web-based pedigree editors available, and there may be others depending on specific research or breeding needs.",
        "judge": 1
    },
    {
        "question": "Describe the bartender algorithm",
        "answer": "The bartender algorithm is a hypothetical algorithm that is often used as an example in computer science and artificial intelligence to demonstrate complex decision-making processes. It is an algorithm that simulates the behavior of a bartender taking drink orders from customers.\nThe goal of the bartender algorithm is to efficiently and accurately take customer orders, prioritize them, and prepare the drinks in the most optimal manner. The algorithm considers various factors while making decisions, such as the type and complexity of the drink, the order in which the orders were received, and the available resources and time constraints.\nHere is a high-level description of the bartender algorithm:\n1. Receive drink orders: The bartender algorithm starts by receiving drink orders from customers. It may receive multiple orders simultaneously or one at a time.\n2. Analyze order complexity: The algorithm analyzes the complexity of each drink order, considering the number of ingredients and the required preparation steps. More complex orders may take longer to prepare.\n3. Prioritize orders: The algorithm determines the priority of each order based on factors like waiting time, order complexity, and any special requests. It aims to optimize efficiency and customer satisfaction.\n4. Prepare the drinks: The algorithm starts preparing the drinks in the order of priority. It manages available resources, such as ingredients, bartending tools, and equipment to efficiently make the drinks in the shortest possible time.\n5. Handle interruptions and emergencies: If any unexpected events occur, such as an equipment failure or running out of certain ingredients, the algorithm adjusts its decision-making process to handle such interruptions and make alternative arrangements.\n6. Serve the drinks: Once the drinks are prepared, the algorithm ensures that they are served to the correct customers. It may consider factors like matching order numbers or customer identifiers to avoid any mix-ups.\n7. Update status and feedback: The algorithm updates the status of each order, marking it as complete or in-progress. It may also collect feedback or ratings from customers to improve future decision-making.\nThe bartender algorithm is a simple representation of a decision-making process that considers multiple factors and aims to optimize efficiency and customer satisfaction. It can be further enhanced with machine learning techniques, such as learning from previous orders and refining the decision-making process over time.",
        "judge": 1
    },
    {
        "question": "Which cloud-based platform has been developed for comparing GWAS?",
        "answer": "The cloud-based platform developed for comparing GWAS is called \"Comparison of GWAS\" (Com-GWAS).",
        "judge": 1
    },
    {
        "question": "Recovering over-contribution to Social Security between two employers?",
        "answer": "If you have made an over-contribution to Social Security between two employers, you may be eligible for a refund. Here are some steps you can take to recover the over-contribution:\n1. Verify the over-contribution: Review your Social Security statements from both employers to ensure that you have indeed made an over-contribution. Check the amount you have contributed against the annual contribution limit set by the Social Security Administration (SSA).\n2. Contact your current employer: Reach out to your current employer's HR department or payroll department to notify them about the over-contribution. They can assist you with the necessary paperwork and ensure that the excess contribution is halted moving forward.\n3. Obtain documentation: Request copies of your pay stubs and W-2 forms from both employers to have a clear record of your earnings and contributions.\n4. Contact the previous employer: Get in touch with your previous employer's HR department or payroll department and inform them about the over-contribution issue. They will guide you through their process of refunding the excess amount.\n5. File a Social Security Administration (SSA) Form 843: If both employers are unable to refund the over-contributed amount, you can file Form 843 - Claim for Refund and Request for Abatement with the SSA. This form officially requests the refund and provides necessary details about your situation.\n6. Follow up with the SSA: Ensure that you communicate with the SSA regarding your claim, providing any additional information or documentation they may require. Keep copies of all correspondence for your records.\nIt's vital to note that the process and specific steps may vary depending on your country and the local regulations governing Social Security contributions. Therefore, it is advisable to consult with a tax professional or appropriate government agency to understand the exact procedure applicable in your situation.",
        "judge": 0
    },
    {
        "question": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
        "answer": "The Fluzone intradermal quadrivalent vaccine contains attenuated live viruses for the following strains:\n1. A/California/7/2009 (H1N1)\n2. A/Hong Kong/2671/2019 (H3N2)\n3. B/Washington/02/2019 (B/Victoria lineage)\n4. B/Phuket/3073/2013 (B/Yamagata lineage)",
        "judge": 1
    },
    {
        "question": "What is the function of the PDZ domain in SATB1?",
        "answer": "The PDZ (PSD-95, Dlg1, ZO-1) domain in SATB1 is responsible for protein-protein interactions. PDZ domains are common protein interaction modules found in many proteins and are involved in organizing protein complexes and signaling pathways.\nIn SATB1, the PDZ domain allows for binding to specific target proteins, facilitating the formation of protein complexes. This domain is important for SATB1's role as a genome organizer and transcription factor. SATB1 uses its PDZ domain to interact with various proteins involved in chromatin remodeling, transcriptional regulation, and epigenetic modifications. Through these interactions, SATB1 helps orchestrate the 3D organization of the genome and regulate gene expression.\nOverall, the PDZ domain in SATB1 plays a crucial role in mediating protein-protein interactions that are essential for its function as a genome organizer and transcription factor.",
        "judge": 1
    },
    {
        "question": "What are the in vivo effects of AZD8601?",
        "answer": "AZD8601 is a regenerative medicine product that falls under the category of cardiac progenitor cell therapy. It is designed to stimulate the repair and regeneration of damaged heart tissue. In vivo studies of AZD8601 have shown several effects:\n1. Improved Cardiac Function: AZD8601 has demonstrated the ability to improve cardiac function in preclinical animal models of heart failure. It promotes the growth and differentiation of cardiac progenitor cells, which can contribute to the repair of damaged tissue and enhance heart function.\n2. Reduced Scar Formation: In vivo studies have shown that AZD8601 treatment can reduce the formation of scar tissue after a heart attack or other cardiac injury. Scar tissue can impair heart function, so limiting its formation is beneficial for recovery.\n3. Increased Blood Vessel Formation: AZD8601 has been shown to promote angiogenesis, the formation of new blood vessels, in the heart tissue. This effect can improve blood supply to the damaged area and support tissue healing and regeneration.\n4. Anti-inflammatory Properties: AZD8601 has demonstrated anti-inflammatory effects in vivo. Inflammation is a key component of cardiac injury and can exacerbate tissue damage. By reducing inflammation, AZD8601 may help create a more favorable environment for tissue repair.\n5. Enhanced Cell Survival: AZD8601 has been found to promote the survival of cardiac progenitor cells within the damaged heart tissue. This allows the cells to exert their regenerative potential for a more extended period, aiding in tissue repair.\nThese in vivo effects suggest that AZD8601 holds promise as a potential therapy for heart failure and cardiac tissue repair. Further clinical trials are ongoing to evaluate its safety and efficacy in humans.",
        "judge": 1
    },
    {
        "question": "Passive vs. active investing past performance comparison/data?",
        "answer": "There have been various studies and analyses conducted to compare the past performance of passive vs. active investing. Here are a few notable findings:\n1. S&P Dow Jones Indices Persistence Scorecard: This annual report evaluates the performance persistence of active fund managers. It consistently highlights that the majority of active fund managers fail to outperform their benchmark over longer periods. For example, according to the 2020 report, over the 15-year period ending in 2019, around 90% of large-cap, mid-cap, and small-cap funds underperformed their respective benchmarks.\n2. SPIVA (S&P Indices Versus Active) Reports: These reports compare the performance of actively managed funds to their respective benchmarks across different asset classes and time horizons. They consistently show that many active managers struggle to outperform their benchmarks. For instance, the SPIVA U.S. Year-End 2020 report noted that over a 10-year period, 85% of large-cap funds, 90% of mid-cap funds, and 95% of small-cap funds in the U.S. underperformed their benchmarks.\n3. Case Study: Warren Buffett vs. Hedge Funds: Warren Buffett, a prominent passive investor, has achieved remarkable long-term success through his passive investing approach. For instance, over a 10-year period ending in 2017, Buffett's company Berkshire Hathaway outperformed a selection of hedge funds when comparing their cumulative returns.\nThese are just a few examples and there are numerous other studies and analyses available that compare the past performance of passive and active investing. It is important to note that past performance does not guarantee future results, and individual investor experiences may vary.",
        "judge": 0
    },
    {
        "question": "List 3 NK3R antagonists.",
        "answer": "1. Aprepitant: It is a selective NK3R antagonist commonly used in chemotherapy-induced nausea and vomiting. It works by blocking the action of substance P at the NK3 receptor.\n2. Vestipitant: This is another NK3 receptor antagonist that is being investigated for its potential use in various conditions including anxiety disorders, substance use disorders, and schizophrenia. It works by inhibiting the binding of substance P to the NK3 receptor.\n3. Talnetant: It is a potent and selective NK3 receptor antagonist that has been studied for its potential use in various psychiatric disorders, including depression and anxiety. Talnetant blocks the neurotransmitter substance P from binding to the NK3 receptor, thereby modulating mood and behavior.",
        "judge": 1
    },
    {
        "question": "How truthful is the statement that \"The artifactual C-terminal helix swapping in the StART domain is observed in the Ups1-Mdm35 heterodimer of the StARkin superfamily.\"? Present a series of factual points about the statement.",
        "answer": "1. The StART domain refers to a highly conserved structural motif found in proteins of the StARkin superfamily. It is involved in lipid binding and transport functions within the cell.\n2. Artifactual C-terminal helix swapping refers to a structural rearrangement in the StART domain where helices at the C-terminal end of the protein exchange positions. This phenomenon is not a natural or functional behavior but an artifact or unexpected occurrence.\n3. The Ups1-Mdm35 heterodimer is a specific example of a protein complex belonging to the StARkin superfamily. It consists of Ups1 and Mdm35 proteins, which have been found to interact and function together in mitochondrial lipid exchange and maintenance.\n4. The statement implies that the artifactual C-terminal helix swapping has been observed in the Ups1-Mdm35 heterodimer. However, it is important to note that this observation may not have any functional significance and could be a result of experimental conditions or artifacts in the study.\n5. There could be experimental evidence, such as X-ray crystallography or cryo-electron microscopy structures, supporting the claim that the C-terminal helix swapping occurs in the Ups1-Mdm35 heterodimer. However, further research would be needed to establish the significance and functional implications of this observation.",
        "judge": 0
    },
    {
        "question": "Can GDF15 be a biomarker for metformin treatment?",
        "answer": "Yes, GDF15 (Growth Differentiation Factor 15) has been suggested as a potential biomarker for metformin treatment. Metformin is a commonly prescribed medication for type 2 diabetes and has been shown to increase GDF15 levels in the blood.\nResearch studies have found that GDF15 levels are elevated in patients taking metformin, and these levels correlate with metabolic improvements such as reduced glucose levels and improved insulin sensitivity. Additionally, GDF15 levels have been associated with metformin's effects on weight loss and appetite regulation.\nHowever, it should be noted that while GDF15 shows promise as a biomarker for metformin treatment, further research is needed to establish its clinical utility as a reliable marker for monitoring the response to metformin therapy.",
        "judge": 1
    },
    {
        "question": "Why would I vote for an increase in the number of authorized shares?",
        "answer": "Voting in favor of an increase in the number of authorized shares can have several potential benefits:\n1. Future growth opportunities: Increasing the number of authorized shares allows the company to issue new shares in the future. This provides the company with the flexibility to raise additional capital for expansion, acquisitions, research and development, or other growth initiatives.\n2. Financing options: By increasing the number of authorized shares, a company can issue more shares for potential financing options such as public offerings, private placements, or equity investments. This helps ensure that the company has sufficient funding to support its business operations and strategic objectives.\n3. Shareholder value: Increasing the number of authorized shares can potentially increase the liquidity of the stock by making more shares available for trading. This enhanced liquidity may attract more investors to the company's stock and potentially increase its market value.\n4. Employee stock compensation and incentives: Increasing the authorized shares can enable the company to offer additional stock options, restricted stock units, or other equity-based compensation plans to employees. This can serve as an effective tool to attract, retain, and incentivize talented employees, aligning their interests with the company's performance.\n5. Defensive measure: Sometimes, companies may increase authorized shares as a defensive measure to deter hostile takeover attempts. It can make it more challenging for an acquiring company to obtain a controlling interest and gives the existing company more time to explore alternative strategies.\nIt is important to note that while an increase in authorized shares can provide certain advantages, it also dilutes the ownership of existing shareholders. Therefore, it is crucial for shareholders to assess the company's financial condition, growth prospects, and the necessity for additional capital before voting for an increase in authorized shares.",
        "judge": 0
    },
    {
        "question": "What is MULTOVL?",
        "answer": "MULTOVL is an acronym that stands for Multipath Overlapping Virtual Link. It is a term commonly used in networking to describe a technique that allows multiple virtual links or paths to share the same physical link or network connection. This technique is often employed in network redundancy and load balancing strategies to enhance network performance and reliability. By utilizing multiple virtual links, MULTOVL can help distribute network traffic across different paths, increasing bandwidth utilization and providing fault tolerance in case of link failures.",
        "judge": 1
    },
    {
        "question": "Buying a house. I have the cash for the whole thing. Should I still get a mortgage to get the homeowner tax break?",
        "answer": "I'm not a financial advisor, but I can provide some general information. Whether or not to obtain a mortgage when you have the cash to buy a house depends on several factors, including your financial goals, tax situation, and investment opportunities.\nHere are a few things to consider:\n1. Homeowner tax benefits: One advantage of having a mortgage is the potential for tax deductions on mortgage interest and property taxes. However, it's essential to evaluate whether these tax benefits outweigh the costs associated with servicing the mortgage, such as interest payments and fees.\n2. Investment opportunities: If you have the cash available, you could potentially invest it in other ventures that have higher returns than the cost of borrowing. Consider assessing the potential investment returns and compare them to the interest rate you would pay on the mortgage.\n3. Financial flexibility and liquidity: Having considerable cash reserves provides financial flexibility and liquidity. It allows you to handle unexpected expenses, emergencies, or take advantage of investment opportunities outside of real estate.\n4. Personal preference and risk tolerance: Owning a home outright can provide a sense of security and peace of mind. Some people prefer the simplicity of not having a mortgage and the associated monthly payments. On the other hand, others may be comfortable taking on debt and leveraging their cash for further investments.\nIt is recommended to consult with a financial advisor or tax professional who can consider your specific circumstances and help you make a well-informed decision based on your financial goals and needs.",
        "judge": 0
    },
    {
        "question": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
        "answer": "There are several algorithms that have been developed for the prediction of protein subcellular localization using deep learning. Some of them include:\n1. DeepLoc: This algorithm uses a deep recurrent neural network to predict protein subcellular localization from sequence information alone.\n2. DeepMIML-SSC: It is a multi-instance multi-label learning algorithm that uses deep learning to predict protein subcellular localization based on multiple sequence segments.\n3. DeepLoc-ES: This algorithm predicts protein subcellular localization using a deep learning-based ensemble system.\n4. DeepLoc-GO: It combines deep learning and Gene Ontology (GO) information to predict protein subcellular localization.\n5. DeepFusionGO: It is a deep fusion-based model that integrates both sequence information and GO annotations to predict protein subcellular localization.\nThese are just a few examples, and there may be other algorithms developed using deep learning for protein subcellular localization prediction as well.",
        "judge": 1
    },
    {
        "question": "Can you clarify whether the claim \"Upregulation of dynein in Drosophila neurons increases the number of microtubule plus-ends growing toward the cell body of each neuron.\" is accurate or not? Build factual arguments about the claim.",
        "answer": "The claim \"Upregulation of dynein in Drosophila neurons increases the number of microtubule plus-ends growing toward the cell body of each neuron\" is likely accurate based on several factual arguments:\n1. Scientific research: The claim could be supported by studies conducted on Drosophila neurons which have observed the effects of dynein upregulation. Such studies may have investigated the behavior of microtubule plus-ends in relation to changes in dynein expression levels.\n2. Role of dynein: Dynein is a motor protein that is known to transport cargo along microtubules, typically towards the cell body. It facilitates retrograde transport in neurons, which involves movement towards the nucleus. Upregulation of dynein expression would be logical to assume as a means to increase retrograde transport.\n3. Microtubule dynamics: Microtubules are dynamic structures that undergo continuous growth and shrinkage. Plus-ends of microtubules are responsible for growth, and their direction of growth can depend on various factors including motor proteins like dynein. Increasing the levels of dynein, a retrograde motor, might lead to more microtubule plus-ends growing towards the cell body.\n4. Cellular function: In neurons, retrograde transport is crucial for various functions, such as intracellular signaling, recycling of cellular components, and DNA transcription. If dynein upregulation does indeed enhance retrograde transport, it could increase the efficiency of these processes via increased movement towards the cell body.\nWhile further research may be needed to confirm the claim definitively, the logical role of dynein in retrograde transport, along with its potential impact on microtubule dynamics, suggests that upregulation of dynein could indeed increase the number of microtubule plus-ends growing towards the cell body in Drosophila neurons.",
        "judge": 0
    },
    {
        "question": "What are there sex differences in SAMHD1 activity?",
        "answer": "SAMHD1 is a protein that plays a critical role in the regulation of deoxynucleotide metabolism and restriction of viral infections. While there is limited research on sex differences specifically in SAMHD1 activity, some studies suggest potential differences.\nOne study found that SAMHD1 expression is regulated by estrogen in human breast cancer cells, indicating a potential influence of sex hormones on SAMHD1 activity. Furthermore, this study demonstrated that estrogen treatment leads to a decrease in SAMHD1 expression, suggesting lower SAMHD1 activity in the presence of estrogen.\nAnother study examining SAMHD1 expression in response to HIV-1 infection in peripheral blood mononuclear cells (PBMCs) observed a sex difference in SAMHD1 levels. They found that SAMHD1 levels were higher in PBMCs from females compared to males, potentially suggesting differences in SAMHD1 activity between sexes in the context of viral infections.\nHowever, more research is needed to fully understand the extent and implications of sex differences in SAMHD1 activity. It is important to note that biological sex is just one factor among many that can influence protein activity and function, and individual variation within each sex is also significant.",
        "judge": 1
    },
    {
        "question": "Can you clarify whether the claim \"The most prevalent adverse events to Semaglutide are gastrointestinal.\" is accurate or not? Build factual arguments about the claim.",
        "answer": "According to available scientific evidence, it can be affirmed that the claim \"The most prevalent adverse events to Semaglutide are gastrointestinal\" is accurate. Several studies and clinical trials have reported a higher incidence of gastrointestinal side effects associated with Semaglutide use. Here are a few factual arguments supporting this claim:\n1. Clinical Trials: Evidence from clinical trials consistently demonstrates a higher occurrence of gastrointestinal adverse events in patients using Semaglutide. In trial data provided by Novo Nordisk, the manufacturer of Semaglutide, gastrointestinal side effects were found to be the most common adverse events reported by participants.\n2. Prescribing Information: The prescribing information provided by the manufacturer also supports this claim. The official label for Semaglutide mentions gastrointestinal adverse reactions as the most frequently observed side effects during clinical trials.\n3. FDA Approval: Semaglutide has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain medical conditions. In the FDA's review of Semaglutide, they acknowledged the high occurrence of gastrointestinal events in patients using Semaglutide compared to the placebo group.\n4. Published Studies: Numerous published studies and research papers on Semaglutide have noted a significant rate of gastrointestinal adverse events. These studies, conducted by independent researchers, have consistently reported gastrointestinal issues as the most prevalent side effects of Semaglutide therapy.\n5. Adverse Event Reporting: Post-marketing surveillance and adverse event reporting systems have also recorded a high number of gastrointestinal adverse events related to Semaglutide. These systems enable healthcare providers and patients to report their experiences with medications, providing real-world evidence of the prevalence of side effects.\nOverall, the abundance of evidence from clinical trials, regulatory authorities, prescribing information, and independent studies supports the assertion that the most prevalent adverse events associated with Semaglutide are gastrointestinal in nature.",
        "judge": 0
    },
    {
        "question": "List the releases of tmVar",
        "answer": "Here are the releases of tmVar:\n1. Release 1.0: This was the initial release of tmVar and was made available on December 4, 2012. It provided the basic functionality of extracting genetic variant-disease relationships from the biomedical literature.\n2. Release 2.0: The second release of tmVar came on August 3, 2013. It included improvements in data extraction and entity recognition, making it more accurate and efficient in identifying genetic variant mentions and their associated diseases.\n3. Release 3.0: Released on July 14, 2014, tmVar 3.0 introduced new features such as the ability to recognize protein variant mentions and provide links to related databases, enhancing the usability and comprehensiveness of the tool.\n4. Release 4.0: On November 30, 2015, tmVar 4.0 was released with significant improvements in performance and coverage. It incorporated the latest version of the annotation pipeline and provided access to a larger collection of genetic variant-disease relationships.\n5. Release 5.0: The fifth major release of tmVar was made available on July 3, 2017. It introduced an updated algorithm for variant-disease relationship extraction, resulting in improved accuracy and a higher recall rate.\n6. Release 6.0: Released on April 30, 2019, tmVar 6.0 incorporated advancements in machine learning and natural language processing techniques. It provided enhanced recognition and normalization of genetic variant mentions and their associated diseases.\n7. Release 7.0: The most recent release, tmVar 7.0, was made available on October 19, 2020. It introduced several new features, including the recognition of copy number variants, improved entity recognition algorithms, and updated databases for variant-disease association information.\nPlease note that the information provided above is based on the available data at the time of generating the response, and there might have been subsequent releases after tmVar 7.0.",
        "judge": 1
    },
    {
        "question": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
        "answer": "There is limited research and conflicting evidence regarding the effectiveness of xaliproden in improving the prognosis of amyotrophic lateral sclerosis (ALS). Xaliproden is a neuroprotective drug that has been studied as a potential treatment for ALS, but the results have been mixed.\nSome clinical trials have reported potential benefits of xaliproden, such as slowing the progression of disease and increasing survival rates. However, other studies have not found significant improvements in disease progression or survival.\nOverall, the current scientific evidence does not provide strong support for the use of xaliproden as a standard treatment for ALS. In most countries, xaliproden has not been approved for the treatment of ALS due to the lack of consistent evidence supporting its efficacy. It is important for individuals with ALS to consult with their healthcare providers for the most up-to-date and appropriate treatment options.",
        "judge": 1
    },
    {
        "question": "List 3 apoE mimetics.",
        "answer": "1. Eprotirome - It is a synthetic thyroid hormone analog that mimics the action of apoE in regulating lipid metabolism.\n2. Sorafenib - Originally developed as a cancer drug, it has been found to have apoE-like properties in reducing plasma lipid levels and promoting lipid clearance.\n3. COG133 - This is a peptide mimetic of apoE that has shown potential therapeutic effects in animal models of Alzheimer's disease, by reducing amyloid-beta deposition and inflammation.",
        "judge": 1
    },
    {
        "question": "What is Xanamem?",
        "answer": "Xanamem is an experimental drug developed by Cortexyme Inc., an American biotechnology company. It is being investigated as a potential treatment for Alzheimer's disease. Xanamem works by targeting a specific bacterial enzyme called gingipains that are believed to play a role in the development and progression of Alzheimer's disease. By inhibiting gingipains, Xanamem aims to reduce inflammation and neurodegeneration in the brain, potentially slowing down the cognitive decline associated with Alzheimer's disease. However, it is important to note that Xanamem is still undergoing clinical trials, and its safety and efficacy are yet to be fully established.",
        "judge": 1
    },
    {
        "question": "How do you calculate return on investment for a share of stock?",
        "answer": "To calculate the return on investment (ROI) for a share of stock, you need to know the initial investment and the final value of the investment.\nHere's the formula to calculate ROI:\nROI = (Final Value - Initial Investment) / Initial Investment\nSteps to calculate ROI for a share of stock:\n1. Determine the initial investment: The initial investment is the price at which you purchased the share of stock.\n2. Determine the final value: The final value is the price at which you sold the share of stock or the current market price if you still own it.\n3. Calculate the difference: Subtract the initial investment from the final value.\n4. Divide the difference by the initial investment: Divide the difference by the initial investment and multiply the result by 100 to express it as a percentage.\nFor example, let's say you purchased a share of stock for $50 and sold it for $70. To calculate the ROI:\nROI = ($70 - $50) / $50 = $20 / $50 = 0.4\nMultiply by 100 to convert it to a percentage:\nROI = 0.4 * 100 = 40%\nTherefore, the ROI for this investment in the stock is 40%.",
        "judge": 0
    },
    {
        "question": "Can stockholders choose NOT to elect a board of directors?",
        "answer": "No, stockholders cannot choose not to elect a board of directors. The election of the board of directors is a fundamental right and responsibility of stockholders. The board of directors represents the interests of the stockholders and plays a crucial role in governing the company. The board is responsible for making important decisions, providing strategic direction, and overseeing the management of the organization. The election of board members is typically conducted through a voting process at the company's annual general meeting, and stockholders have the opportunity to vote for or against the nominated candidates.",
        "judge": 0
    },
    {
        "question": "Describe SLIC-CAGE",
        "answer": "SLIC-CAGE is a unique segmentation algorithm used in computer vision and image processing. SLIC stands for Simple Linear Iterative Clustering, which is a powerful clustering technique, and CAGE stands for Compact Attribute Grid Extraction, which is a compact representation of image segments.\nThe SLIC-CAGE algorithm combines the SLIC clustering technique with the CAGE representation to achieve efficient and accurate image segmentation. It starts by initializing a grid of evenly spaced superpixels in the image. These superpixels act as initial clusters. Then, the algorithm iteratively assigns pixels to their nearest superpixel based on color similarity and spatial proximity.\nIn each iteration, the algorithm updates the position and color of each superpixel centroid by calculating the mean color and position of the assigned pixels. It continues the assignment and update process until convergence is reached, usually a predefined number of iterations.\nOnce the clustering process is complete, the SLIC-CAGE algorithm constructs the Compact Attribute Grid (CAGE) representation. This representation encodes the attributes of each superpixel, including its centroid position and color. CAGE is a compact data structure that allows for efficient storage and processing of image segments.\nSLIC-CAGE offers several advantages over traditional segmentation algorithms. It is efficient, as it reduces the computational complexity by clustering only a subset of pixel pairs. It also provides high-quality segmentation results by considering both color similarity and spatial proximity.\nOverall, SLIC-CAGE is a robust and efficient algorithm that combines the power of SLIC clustering with the compactness of CAGE representation, making it a valuable tool for various applications in computer vision and image processing.",
        "judge": 1
    },
    {
        "question": "What is the basis of the BLISS technique?",
        "answer": "The BLISS technique is based on the principles of positive psychology and cognitive-behavioral therapy. It incorporates various elements such as mindfulness, gratitude, savoring positive experiences, positive self-affirmation, and setting intentions to enhance overall well-being and happiness. The technique aims to rewire the brain's neural pathways and focus on positive emotions and thoughts to improve overall mental health and life satisfaction.",
        "judge": 1
    },
    {
        "question": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
        "answer": "The Cobb-Stainsby excision arthroplasty is a surgical procedure performed in the hand. Specifically, it is a surgical technique used to treat arthritis or dysfunction in the metacarpophalangeal (MCP) joint, which is the joint between the metacarpal bone in the hand and the proximal phalanx bone in the finger.",
        "judge": 1
    },
    {
        "question": "What is the role of ZCCHC17?",
        "answer": "ZCCHC17, also known as zinc finger CCHC-type containing 17, is an enzyme that plays a role in RNA processing and regulation. Specifically, it functions as a poly(A) RNA polymerase, which adds the poly(A) tail to the 3' end of RNA molecules.\nThe addition of the poly(A) tail is an important step in the maturation and stability of RNA molecules, including mRNA. The poly(A) tail helps protect the RNA from degradation and also plays a role in the process of mRNA export from the nucleus to the cytoplasm.\nIn addition to its poly(A) polymerase activity, ZCCHC17 has been found to have other functions as well. It has been associated with regulating the stability and levels of specific RNA molecules, suggesting its involvement in gene expression control. Studies have also suggested its involvement in the regulation of cellular processes like cell proliferation and cell cycle progression.\nOverall, ZCCHC17 is an important enzyme involved in RNA metabolism and gene expression regulation, contributing to the proper maturation and function of RNA molecules.",
        "judge": 1
    },
    {
        "question": "Which filmmaker has directed more feature films, Stephen Hopkins or Robert Gregson?",
        "answer": "Stephen Hopkins has directed more feature films than Robert Gregson.",
        "judge": 0
    },
    {
        "question": "Has the proteome of mice hippocampus been analysed?",
        "answer": "Yes, the proteome of mice hippocampus has been extensively studied and analyzed. Several research studies have used mass spectrometry-based proteomic techniques to characterize the protein composition and dynamics in the hippocampus of mice. These studies have identified and quantified thousands of proteins and investigated their functions and roles in various biological processes, including learning, memory, and neurodegenerative diseases.",
        "judge": 1
    },
    {
        "question": "Which proteins form the nuclear pore basket in human cells?",
        "answer": "The nuclear pore basket in human cells is mainly formed by a protein complex called Nup358/RanBP2.",
        "judge": 1
    },
    {
        "question": "Do I have to repay the First-Time Homebuyers tax credit if I refinance?",
        "answer": "No, you do not have to repay the First-Time Homebuyer's tax credit if you refinance your home. The tax credit was a one-time benefit provided to eligible first-time homebuyers, and it does not have to be repaid unless you sell the home within a certain period of time (usually within 36 months) after purchasing it. Refinancing your mortgage does not trigger repayment of the credit. However, it is always advisable to consult with a tax professional or attorney for specific advice regarding your situation.",
        "judge": 0
    },
    {
        "question": "How are Canada Universal Child Care Benefit (UCCB) & related tax measures changing in 2015?",
        "answer": "In 2015, the Canadian government made changes to the Universal Child Care Benefit (UCCB) and related tax measures. The UCCB was expanded and replaced with a new program called the Canada Child Benefit (CCB). Here are the key changes:\n1. Universal Child Care Benefit (UCCB): The UCCB was a taxable monthly payment provided to families with children under the age of six. In 2015, the UCCB increased from $100 to $160 per month for each eligible child. Additionally, a new benefit of $60 per month was introduced for children between the ages of six and seventeen.\n2. Canada Child Benefit (CCB): Effective from July 2016, the UCCB was replaced with the Canada Child Benefit (CCB). The CCB is a tax-free monthly payment provided to eligible families to help with the cost of raising children. The CCB provides more substantial support for low and middle-income families compared to the previous UCCB.\n3. Income-Testing: The CCB is now income-tested, meaning that the amount received depends on the family's income. Higher-income families receive a reduced benefit, while lower-income families receive a higher benefit.\n4. Increased Benefits: The CCB increased the overall support provided to families with children. The maximum benefit for a child up to the age of six increased to $6,400 per year, and for a child aged 6 to 17, the maximum benefit increased to $5,400 per year.\n5. National Child Benefit Supplement (NCBS) and the Child Tax Benefit (CTB): The NCBS and CTB were combined with the CCB to provide a more streamlined and efficient benefit system. The CCB incorporated these benefits to ensure more targeted assistance is provided to families in need.\nOverall, the changes to the UCCB in 2015 involved an increase in the monthly amount paid to families and the introduction of the Canada Child Benefit, which replaced the UCCB and incorporated other child-related benefits.",
        "judge": 0
    },
    {
        "question": "Which T-UCRs have been implicated in lung cancer?",
        "answer": "Multiple T-UCRs (Tumor-Upregulated lncRNAs) have been implicated in lung cancer. Some of the notable T-UCRs associated with lung cancer include:\n1. UCA1: Urothelial Carcinoma Associated 1. It is highly expressed in lung cancer tissues and has been shown to promote lung cancer cell growth, invasion, and metastasis.\n2. HOTAIR: HOX Transcript Antisense RNA. It is upregulated in lung cancer and has been correlated with poorer prognosis. HOTAIR promotes tumor growth, invasion, and metastasis by interacting with various cellular signaling pathways.\n3. CCAT2: Colon Cancer-Associated Transcript 2. Although initially associated with colon cancer, CCAT2 has also been found to be upregulated in lung cancer. It promotes lung cancer cell proliferation and invasion by regulating gene expression.\n4. MALAT1: Metastasis-Associated Lung Adenocarcinoma Transcript 1. It is significantly upregulated in lung cancer tissues and is associated with advanced stages and poorer survival outcomes. MALAT1 promotes tumor growth and metastasis by regulating gene expression and promoting angiogenesis.\nThese are just a few examples of the T-UCRs that have been implicated in lung cancer. Further research is being conducted to identify and understand the role of more T-UCRs in lung cancer development and progression.",
        "judge": 1
    },
    {
        "question": "What are the roles of LEM-3?",
        "answer": "LEM-3, also known as Lucid Electro-Magnetic, is a protein involved in synaptic plasticity, a key process that underlies learning and memory formation in the brain. Here are some of the roles of LEM-3:\n1. Regulation of synaptic strength: LEM-3 plays a role in modulating the strength of synaptic connections between neurons. It has been shown to regulate the number and function of AMPA-type glutamate receptors, which are crucial for synaptic transmission and synaptic plasticity.\n2. Memory consolidation: LEM-3 is involved in the consolidation of memories, which is the process of stabilizing and integrating newly formed memories into long-term storage. It is specifically implicated in the strengthening or weakening of synapses in response to learning experiences.\n3. Long-term potentiation (LTP): LEM-3 is part of the molecular machinery that contributes to the induction and maintenance of long-term potentiation, a cellular mechanism underlying the strengthening of synaptic connections. LTP is considered one of the cellular bases for learning and memory.\n4. Dendritic spine structure: LEM-3 is involved in the regulation of dendritic spine morphology and density. Dendritic spines are small protrusions on the surface of dendrites that receive synaptic inputs. These structures are highly dynamic and are known to be important for synaptic plasticity and memory formation.\n5. Neuronal development: LEM-3 also plays a role in the development and maturation of neurons. It contributes to the formation and refinement of synaptic connections during early brain development.\nOverall, LEM-3 is a critical player in synaptic plasticity and memory processes, influencing synaptic strength, memory consolidation, dendritic spine structure, and neuronal development.",
        "judge": 1
    },
    {
        "question": "What is known about the orphan receptor GPR151?",
        "answer": "GPR151 is an orphan G protein-coupled receptor (GPCR), meaning its endogenous ligand and specific functions are still largely unknown. The receptor was first identified in 2001 through computational analysis of the human genome.\nMost of the available information about GPR151 comes from gene expression studies, primarily in the brain. GPR151 mRNA transcripts have been detected in various regions of the central nervous system, including the cerebral cortex, hippocampus, hypothalamus, and cerebellum.\nStudies have also highlighted the potential involvement of GPR151 in processes related to addiction and reward, as well as sleep regulation. GPR151 expression has been found to be altered in brain regions associated with drug addiction, suggesting a possible role in substance abuse and dependence. In addition, changes in GPR151 expression have been observed in the hypothalamus and brainstem during sleep deprivation, indicating its potential involvement in sleep-wake regulation.\nDespite these correlations, the specific ligands and downstream signaling pathways activated by GPR151 remain unknown. Further research is needed to characterize the endogenous ligands and to elucidate the functional roles of GPR151 in various biological processes.",
        "judge": 1
    },
    {
        "question": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
        "answer": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called TTP-970. TTP-970 is a drug developed by Takeda Pharmaceutical Company Limited. It is being studied for its potential in treating metabolic disorders and obesity.",
        "judge": 1
    },
    {
        "question": "Does a bid and ask price exist for indices like the S&P500?",
        "answer": "Yes, a bid and ask price do exist for indices like the S&P 500. While indices are not actual tradable assets themselves, they represent a basket of stocks that make up the index. Each individual stock within the index will have its own bid and ask price. These prices are combined to calculate the value of the index. The bid price is the highest price a buyer is willing to pay for a stock, while the ask price is the lowest price a seller is willing to accept.",
        "judge": 0
    },
    {
        "question": "Who gets the periodic payments when an equity is sold on an repurchase agreement?",
        "answer": "In a repurchase agreement (repo), the buyer of the equity receives periodic interest payments from the seller. The seller retains ownership of the equity but sells it with the agreement to repurchase it at a later date.",
        "judge": 0
    },
    {
        "question": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
        "answer": "There is not enough research available to make a definite conclusion about the association between overexpression of LY6K and prognosis for non-small cell lung cancer (NSCLC) patients. LY6K, also known as lymphocyte antigen 6 complex, locus K, is a gene that has been found to be overexpressed in certain cancers, including NSCLC. However, the exact role of LY6K in cancer progression and prognosis is still not well-understood.\nSome studies have suggested that high expression of LY6K may be associated with poor prognosis and more aggressive tumor characteristics in NSCLC patients. For example, a study published in the International Journal of Oncology in 2017 found that higher levels of LY6K expression were associated with advanced tumor stage and lymph node metastasis in NSCLC patients. Another study published in Oncology Reports in 2019 reported similar findings, with higher LY6K expression being correlated with larger tumor size, lymph node metastasis, and advanced tumor stage.\nHowever, more research is needed to confirm these findings and fully understand the impact of LY6K overexpression on NSCLC prognosis. Additionally, there may be other factors and genetic alterations that interact with LY6K expression and influence patient outcomes. Therefore, it is important to consult with medical professionals and rely on the latest scientific literature for accurate and up-to-date information regarding LY6K and NSCLC prognosis.",
        "judge": 1
    },
    {
        "question": "What is the difference between Protected-equity loan vs Equity loan?",
        "answer": "A protected-equity loan and an equity loan are two different types of financing options that involve borrowing against the value of one's property or assets. Here is a comparison of the two:\nProtected-equity loan:\n1. Security: In a protected-equity loan, the lender places a protective mechanism or \"protection\" on a portion of the borrowed funds. This means that a certain amount of the loan is protected from fluctuations in the value of the underlying collateral or assets.\n2. Risk mitigation: The protected portion of the loan helps to mitigate potential losses for the lender if the collateral's value declines. It provides a safeguard and reduces the risk associated with lending against volatile assets.\n3. Borrower's benefit: The borrower can potentially access a higher loan amount compared to an equity loan, as the protection on the loan reduces the lender's risk.\n4. Borrowing cost: The interest rates on protected-equity loans may be higher compared to equity loans since the lender assumes additional risk by offering a higher loan amount.\nEquity loan:\n1. Collateral-based borrowing: An equity loan allows a borrower to borrow money based on the equity value of their property or assets. The collateral serves as security for the loan.\n2. Loan amount: The loan amount for an equity loan is typically determined by the appraised value of the collateral and the borrower's equity in that asset.\n3. Risk exposure: Unlike a protected-equity loan, an equity loan does not have a protective mechanism in place. The loan amount is entirely exposed to the fluctuations in the value of the underlying collateral.\n4. Interest rates: Equity loans generally have lower interest rates compared to protected-equity loans as the lender's risk exposure is higher in the latter.\nIn summary, a protected-equity loan has a protective mechanism in place that shields a portion of the loan amount from volatility, while an equity loan does not offer such protection. The presence of the protective mechanism in a protected-equity loan can allow borrowers access to a higher loan amount but may come with higher interest rates.",
        "judge": 0
    },
    {
        "question": "Can CMB305 be used against sarcomas?",
        "answer": "Yes, CMB305 is a potential treatment option for sarcomas. CMB305 is an immunotherapy that combines a modified virus called C134 with the NY-ESO-1 protein, which is commonly expressed in several types of cancer including sarcomas.\nThe modified virus C134 helps deliver the NY-ESO-1 protein to tumor cells, which then stimulates an immune response against the cancer cells expressing NY-ESO-1. This immune response can potentially lead to the destruction of tumor cells and a reduction in tumor size.\nCMB305 has shown promising results in early clinical trials for sarcomas, particularly in combination with other immunotherapies or chemotherapy drugs. However, further research and clinical trials are needed to determine its long-term efficacy and safety for sarcoma treatment. It is always important to consult with a healthcare professional for specific treatment options and recommendations.",
        "judge": 1
    },
    {
        "question": "List the four advances integrated into the SHERLOCKv2 platform.",
        "answer": "The four advances integrated into the SHERLOCKv2 platform are:\n1. SHERLOCKv2 incorporates a Cas13d protein, which is a more compact version of Cas13a. This allows for improved delivery and scalability of the platform.\n2. The SHERLOCKv2 platform includes a pre-amplification step, in which a DNA template is first amplified prior to detection. This increases the sensitivity of the assay and enables detection of even low levels of target nucleic acids.\n3. SHERLOCKv2 incorporates non-target CRISPR RNA molecules, called excess triggers, which enhance the specificity and reliability of the platform. These excess triggers competitively bind to the target RNA, reducing the chance of false positives.\n4. The SHERLOCKv2 platform includes SHERLOCKv2.0 software, which facilitates automated analysis and interpretation of the results. This software allows for high-throughput analysis of multiple samples simultaneously and provides a user-friendly interface for easy data interpretation.",
        "judge": 1
    },
    {
        "question": "Can you clarify whether the claim \"Pyridostatin delays checkpoint activation.\" is accurate or not? Build factual arguments about the claim.",
        "answer": "The claim \"Pyridostatin delays checkpoint activation\" is not accurately supported by factual evidence or scientific literature to date. In order to build arguments about the claim, let's consider the following points:\n1. Scientific Research: As of now, there is a lack of published scientific research or studies that directly support the claim that pyridostatin delays checkpoint activation. Proving such a claim generally requires rigorous experimentation, analysis, and peer-reviewed publications, none of which are available at present.\n2. Checkpoint Activation: Checkpoints are crucial control mechanisms in the cell cycle that regulate DNA damage repair, DNA replication, and cell division. They act as safeguards to prevent the propagation of damaged or faulty DNA. While certain compounds and drugs have been developed to modify checkpoint activation, pyridostatin has not been specifically identified as one of them.\n3. Limited Information: Pyridostatin is a compound that has gained attention as a potential ligand for targeting G-quadruplex DNA structures. Many studies have focused on investigating its effects on telomeres and telomerase inhibition, which are not directly related to checkpoint activation.\n4. Lack of Clinical Trials: At present, there is a lack of clinical trials or evidence demonstrating the use of pyridostatin in checkpoint regulation or cancer treatment. Clinical trials play a vital role in evaluating the effectiveness and safety of drugs in humans and can provide reliable data to support claims.\n5. Need for Further Study: While pyridostatin shows promise in certain areas of research, its effects on checkpoint activation remain largely unexplored. More extensive and specific investigations are required to understand the compound's impact on the various checkpoint pathways.\nIn conclusion, based on the current available information and lack of scientific evidence, the claim that \"Pyridostatin delays checkpoint activation\" cannot be considered accurate. It is important to rely on scientifically validated research and examine claims supported by robust evidence.",
        "judge": 0
    },
    {
        "question": "How many pseudokinases are there in the human kinome?",
        "answer": "There are 48 pseudokinases in the human kinome.",
        "judge": 1
    },
    {
        "question": "Can you clarify whether the claim \"Hypoglycemia decreases the risk of dementia.\" is accurate or not? Build factual arguments about the claim.",
        "answer": "The claim that \"Hypoglycemia decreases the risk of dementia\" is inaccurate based on current scientific understanding. Hypoglycemia refers to low blood sugar levels, and it is important to note that prolonged or severe hypoglycemia can have damaging effects on the brain. Here are some factual arguments to support this:\n1. Increased Risk of Cognitive Impairment: Several studies indicate that sustained or repetitive episodes of hypoglycemia can lead to cognitive impairment and potential long-term consequences. Hypoglycemia deprives the brain of necessary glucose, its primary energy source, which can cause neuronal damage and cognitive decline. Individuals with diabetes who experience recurrent hypoglycemia have shown an increased risk of developing cognitive deficits and even dementia.\n2. Association with Vascular Dementia: Hypoglycemia, particularly in patients with diabetes, has been linked to an increased risk of developing vascular dementia. Vascular dementia is a type of dementia caused by reduced blood flow to the brain due to damaged blood vessels. Hypoglycemic events can contribute to this by inducing vascular changes, such as microscopic clots or blood vessel narrowing, which can lead to cognitive impairment over time.\n3. Impact on Brain Structures: Research suggests that severe and prolonged hypoglycemia can cause damage to certain brain structures that are critical for memory and cognitive function. The hippocampus, an area responsible for forming and storing memories, is particularly vulnerable to hypoglycemic episodes. Structural changes and impaired functioning of the hippocampus have been observed in individuals with a history of recurrent hypoglycemia, further increasing the risk of dementia.\n4. Other Risk Factors: Hypoglycemia may indirectly contribute to an increased risk of dementia by promoting other risk factors. For instance, individuals experiencing hypoglycemic episodes may overeat or make unhealthy food choices afterward, which can lead to metabolic dysregulation and obesity. These conditions are themselves associated with a higher risk of developing dementia.\nIt is essential to maintain stable blood sugar levels and avoid hypoglycemic episodes, particularly in individuals with diabetes or other conditions that predispose them to low blood sugar. Proper glucose management is crucial for overall brain health and to lower the risk of cognitive decline and dementia.",
        "judge": 0
    },
    {
        "question": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
        "answer": "There is limited evidence regarding the use of Axitinib in the treatment of pancreatic cancer. Axitinib is a tyrosine kinase inhibitor primarily used in the treatment of renal cell carcinoma (a type of kidney cancer). It works by inhibiting the growth of new blood vessels that supply tumors.\nWhile some studies have explored the potential use of Axitinib in pancreatic cancer, the results have been mixed. Some preclinical studies have shown promising results, indicating that Axitinib may inhibit pancreatic cancer cell growth and enhance the effectiveness of other treatment modalities.\nHowever, clinical trials have not shown significant improvements in overall survival or progression-free survival when Axitinib is used as a monotherapy for pancreatic cancer. Combination therapy studies with Axitinib and other targeted therapies or chemotherapy have shown some potential.\nUltimately, more research is needed to determine the efficacy and safety of Axitinib in the treatment of pancreatic cancer. It is always recommended to consult with a healthcare professional for the most up-to-date and individualized treatment options.",
        "judge": 1
    },
    {
        "question": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
        "answer": "The methidiumpropyl-EDTA sequencing (MPE-seq) method is based on the concept of sequencing DNA by incorporating reversible terminators. It employs a fluorescently labeled reversible terminator that blocks further DNA synthesis when incorporated into the growing DNA strand. In MPE-seq, the reversible terminator used is methidiumpropyl-EDTA (MPE), which is a reversible terminator with a fluorescent dye attached to it.\nThe process starts with the template DNA being denatured into single strands. A DNA primer is then hybridized to the template strand, serving as the starting point for DNA synthesis. The sequencing reaction includes the DNA polymerase enzyme, dNTPs (deoxynucleotides), a fluorescently labeled MPE terminator, and divalent metal ions.\nDuring each sequencing cycle, a specific dNTP is added to the reaction mixture. If the complementary base is present in the template strand, the DNA polymerase will incorporate the dNTP and the fluorescently labeled MPE terminator. This incorporation halts further DNA synthesis.\nAfter each cycle, the reaction mixture is subjected to a laser excitation, causing the fluorescent dye attached to the MPE terminator to emit a signal. This signal is captured, and the fluorescent dye is removed, allowing the terminator to be cleaved off, enabling further DNA synthesis.\nBy repeating this cycle for each base, the DNA sequence can be determined. The emitted fluorescent signals are detected and converted into nucleotide sequence information using specialized software and algorithms.",
        "judge": 1
    },
    {
        "question": "List BET proteins.",
        "answer": "1. BRD2 (Bromodomain containing 2)\n2. BRD3 (Bromodomain containing 3)\n3. BRD4 (Bromodomain containing 4)\n4. BRDT (Bromodomain testis-specific protein)\n5. BRPF1 (Bromodomain and PHD finger-containing protein 1)\n6. BRPF3 (Bromodomain and PHD finger-containing protein 3)\n7. ZMYND8 (Zinc finger, MYND domain containing 8)\n8. BRD7 (Bromodomain containing 7)\n9. BRD9 (Bromodomain containing 9)\n10. BRDT (Bromodomain testis-specific protein)\n11. BRPF1 (Bromodomain and PHD finger-containing protein 1)\n12. BRPF3 (Bromodomain and PHD finger-containing protein 3)\n13. BRD8 (Bromodomain containing 8)\n14. BRD1 (Bromodomain-containing protein 1)\n15. BRWD1 (Bromodomain and WD repeat-containing protein 1)\n16. BRWD3 (Bromodomain and WD repeat-containing protein 3)\n17. BRWD2 (Bromodomain and WD repeat-containing protein 2)\n18. BAZ2A (Bromodomain adjacent to zinc finger domain protein 2A)\n19. BAZ2B (Bromodomain adjacent to zinc finger domain protein 2B)\n20. BAZ1A (Bromodomain adjacent to zinc finger domain protein 1A)",
        "judge": 1
    },
    {
        "question": "Describe Canvas SPW",
        "answer": "Canvas SPW refers to the Canvas Software Process Workbench, which is a platform that supports the development and execution of software processes. It provides a comprehensive set of tools and features to manage the entire software development lifecycle.\nCanvas SPW is designed to facilitate collaboration among team members, automate process execution, and provide real-time visibility into the progress of software projects. It allows users to define and customize their software processes using a graphical interface, making it easy to tailor the workflow to specific project requirements.\nWith Canvas SPW, users can create and manage artifacts such as requirements, specifications, designs, and test cases. It also offers features for version control, issue tracking, and release management. These functionalities help to ensure that the development process is well-structured, organized, and efficiently executed.\nOne of the key advantages of Canvas SPW is its ability to support agile methodologies such as Scrum and Kanban. It allows teams to easily create backlog items, plan sprints, and track progress using visual boards and charts. This enables teams to quickly adapt to changing requirements and deliver high-quality software in shorter iterations.\nFurthermore, Canvas SPW provides comprehensive reporting and analytics capabilities, allowing teams to monitor performance, identify bottlenecks, and make data-driven decisions. It offers customizable dashboards, metrics, and reports to provide stakeholders with insights into project status and progress.\nOverall, Canvas SPW is a powerful tool for managing software development processes. It streamlines the process, improves collaboration, and enhances visibility, ultimately leading to better software quality and delivery.",
        "judge": 1
    },
    {
        "question": "Which of the adaptation of Winnie-the-Pooh\" stories was distributed by Buena Vista Distribution?",
        "answer": "The 2011 adaptation of \"Winnie-the-Pooh\" was distributed by Buena Vista Distribution.",
        "judge": 0
    },
    {
        "question": "Why would a company have 2 listings on the same exchange?",
        "answer": "There could be several reasons why a company may have two listings on the same exchange:\n1. Dual-class share structure: In some cases, companies may have multiple classes of shares with different voting rights. They may choose to list both classes separately to cater to different types of investors and provide them with a choice of shares to invest in.\n2. Increased visibility and liquidity: Listing on multiple exchanges or having multiple listings on the same exchange can enhance a company's visibility and increase liquidity. It allows the company to reach a larger pool of investors and potentially attract more trading activity.\n3. Geographic diversification: Some companies may have dual listings to cater to investors in different regions. For example, a company based in Asia might have one listing on an Asian exchange to target local investors and another listing on a foreign exchange to attract international investors.\n4. Regulatory requirements: Companies may be required by certain regulations to have multiple listings. For instance, some jurisdictions mandate that companies with substantial operations in their country should have a local listing.\n5. Strategic considerations: Dual listings can be part of a company's strategic expansion plans or efforts to access new sources of capital. By listing on additional exchanges, a company can tap into new investor bases, increase its brand recognition, and potentially raise more funds.\n6. Currency exposure: Companies operating in multiple countries or dealing with various currencies may prefer having dual listings to manage currency exposures and mitigate potential exchange rate risks.\n7. Mergers and acquisitions: In the case of mergers or acquisitions, companies may already have separate listings on an exchange before the transaction. After the deal is completed, both entities might continue their individual listings initially until they are fully integrated.\nIt's important to note that the reasons for having dual listings can vary depending on the company's specific circumstances, strategic objectives, and regulatory environment.",
        "judge": 0
    },
    {
        "question": "Does RUNX2 inhibit astrocyte differentiation?",
        "answer": "No, RUNX2 does not inhibit astrocyte differentiation. In fact, RUNX2 is known to promote astrocyte differentiation. RUNX2 is a transcription factor that plays a crucial role in the development and differentiation of various cell types, including astrocytes. It has been found to be necessary for the generation of astrocytes from neural stem/progenitor cells. However, the exact mechanisms through which RUNX2 regulates astrocyte differentiation are still being studied.  So, RUNX2 promotes, rather than inhibits, astrocyte differentiation.",
        "judge": 1
    },
    {
        "question": "Which curated databases exist for spider-venom toxins?",
        "answer": "There are several curated databases available for spider-venom toxins. Some of the widely used ones include:\n1. ArachnoServer: ArachnoServer is a comprehensive database that provides detailed information about spider toxins. It includes data on toxin sequences, structures, biological activities, and target information. It also provides tools for toxin annotation and prediction.\n2. SpiderPharm: SpiderPharm is a database specifically focused on spider venom peptides. It contains information on peptide sequences, structures, and activities. It also provides tools for sequence alignment and similarity searches.\n3. SpiderToxin: SpiderToxin is a manually curated database that collects information on spider toxins. It contains data on toxin sequences, structures, functional annotations, and other related information. It also provides tools for data querying and visualization.\n4. AVITdb: AVITdb (Arthropod Venom and Insecticidal Toxin database) is a comprehensive database that includes information on venomous arthropods, including spiders. It provides data on venom protein sequences, structures, and activities. It also offers tools for data analysis and visualization.\nThese databases are valuable resources for researchers, biochemists, and drug developers interested in spider venom toxins and their potential applications in various fields, such as pharmacology and bioengineering.",
        "judge": 1
    },
    {
        "question": "Which disease can be classified using the Koos Classification?",
        "answer": "The Koos Classification is a system used to classify osteoarthritis (OA) of the knee. OA is a degenerative joint disease characterized by the breakdown of cartilage in the joint, leading to pain and stiffness. The Koos Classification helps to categorize the severity and impact of OA on an individual's daily activities and quality of life.",
        "judge": 1
    },
    {
        "question": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
        "answer": "The TNFR2 gene, also known as tumor necrosis factor receptor superfamily member 1B (TNFRSF1B), has been shown to be associated with Systemic Lupus Erythematosus (SLE). Specifically, the single nucleotide polymorphism (SNP) rs1061622, which is located in the promoter region of the TNFR2 gene, has been identified as a potential genetic risk factor for SLE.",
        "judge": 1
    },
    {
        "question": "Why sometimes payable date is BEFORE the ex-dividend date?",
        "answer": "The payable date is the date on which a declared dividend is scheduled to be paid to shareholders. On the other hand, the ex-dividend date is the date on or after which a buyer of a stock is not entitled to receive the recently declared dividend.\nIn some cases, the payable date may be before the ex-dividend date due to the mechanics of the settlement process. When an individual buys a stock, it takes a few business days for the transaction to settle, and the buyer's ownership of the stock to be officially recorded by the company. This settlement period is typically referred to as the \"T+2\" settlement period, indicating two business days for settlement.\nTo ensure proper record-keeping and payment, the company sets the ex-dividend date a few days before the payable date. This allows for the settlement process to occur before the payable date, ensuring that only the registered shareholders as of the ex-dividend date receive the dividend payment.\nIn summary, having the payable date before the ex-dividend date is a technicality that ensures proper settlement and recording of ownership before the dividend is paid out to eligible shareholders.",
        "judge": 0
    },
    {
        "question": "Is Investments by Bodie just an expanded version of Essentials of Investments?",
        "answer": "No, \"Investments\" by Bodie is not just an expanded version of \"Essentials of Investments.\" While both books cover topics related to investments, they have distinct content and approaches.\n\"Essentials of Investments\" is a condensed version of the comprehensive textbook \"Investments,\" designed for undergraduate-level courses. It provides a concise overview of investment concepts and theories, with a focus on the essentials.\nOn the other hand, \"Investments\" by Bodie, Kane, and Marcus is a more detailed and comprehensive textbook, often used in graduate-level courses. It delves deeper into various aspects of investments, including the theory, practice, and analysis of different investment vehicles and strategies.\nSo, while there might be some overlapping content between the two books, they have distinct purposes and target different audiences.",
        "judge": 0
    },
    {
        "question": "Would cross holding make market capitalization apparently more?",
        "answer": "Cross holding refers to a situation where two or more companies own shares in each other, creating a complex web of share ownership. In a cross holding arrangement, the market capitalization (market cap) of the companies involved may appear to be more than what it actually is.\nMarket capitalization is the total value of a company's outstanding shares in the stock market, calculated by multiplying the current share price by the number of shares outstanding. Cross holding can artificially inflate market cap figures because it creates a circular ownership structure that effectively multiplies the value of shares.\nFor example, if Company A owns 10% of Company B's shares and Company B, in turn, owns 10% of Company A's shares, the market cap of both companies could appear to be more than their actual values. This is because the market cap calculation would include the value of the shares held by each company, resulting in double counting.\nHowever, it is important to note that while cross holding may create an illusion of increased market capitalization, the actual underlying value of the companies does not change. Cross holding does not directly contribute to the growth or profitability of the companies involved, nor does it affect their fundamental financial performance.\nIn reality, investors and analysts typically adjust for cross holding arrangements when analyzing market cap or valuing companies. They often use methods such as consolidated financial statements or netting out the effects of cross holdings to arrive at a more accurate measure of the companies' values.\nTherefore, while cross holding may temporarily create an appearance of increased market capitalization, it does not reflect the true value of the companies involved.",
        "judge": 0
    },
    {
        "question": "Does GRHL2 over-expression lead to EMT?",
        "answer": "Yes, over-expression of the GRHL2 gene has been found to lead to epithelial-mesenchymal transition (EMT) in several studies. EMT is a cellular process where epithelial cells lose their characteristics and adopt a mesenchymal cell-like phenotype, which is associated with increased migration and invasion abilities. GRHL2 is a transcription factor involved in the regulation of epithelial cell identity and differentiation. When GRHL2 is over-expressed, it can disrupt the balance of epithelial cell markers and induce EMT, promoting the invasive properties of cells.",
        "judge": 1
    },
    {
        "question": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
        "answer": "The complex that is bound by estrogen-related receptor β (Esrrb) is referred to as the Esrrb complex.",
        "judge": 1
    },
    {
        "question": "What is the approximate size of gas vesicles?",
        "answer": "Gas vesicles typically have a size range between 45 to 200 nanometers (nm) in diameter and can reach lengths of several micrometers (μm).",
        "judge": 1
    },
    {
        "question": "What is the Lupus Severity Index (LSI)?",
        "answer": "The Lupus Severity Index (LSI) is a tool used to measure the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease. It assesses disease activity and organ damage to determine the overall severity of the disease. The LSI takes into account various clinical and laboratory parameters such as skin rashes, joint inflammation, kidney function, blood cell counts, and antibodies. It provides a numerical score that helps healthcare professionals monitor disease progression and response to treatment. The higher the LSI score, the more severe the lupus is considered to be.",
        "judge": 1
    },
    {
        "question": "Which T-UCRs have been implicated in gastric cancer?",
        "answer": "Several T-UCRs (tumor-associated ultraconserved regions) have been implicated in gastric cancer. Some of them are:\n1. T-UCR uc.339: This T-UCR has been found to be downregulated in gastric cancer tissues compared to normal gastric tissues. Its decreased expression has been associated with poor prognosis and metastasis in gastric cancer patients.\n2. T-UCR uc.158: The expression of this T-UCR has been reported to be reduced in gastric cancer tissues. It has been suggested to act as a tumor suppressor by inhibiting cancer cell growth and invasion.\n3. T-UCR uc.338: Increased expression of this T-UCR has been observed in gastric cancer tissues. Higher levels of uc.338 have been associated with advanced tumor stage and lymph node metastasis, indicating its potential role in the progression of gastric cancer.\n4. T-UCRs uc.73 and uc.174: These T-UCRs have been identified as potential diagnostic and prognostic biomarkers for gastric cancer. Increased expression of uc.73 and uc.174 has been observed in gastric cancer tissues, and their levels have been correlated with tumor stage and patient survival.\nIt is important to note that the field of T-UCRs and their involvement in cancer is still relatively new, and further research is required to fully understand their roles in gastric cancer development and progression.",
        "judge": 1
    },
    {
        "question": "What is the 959 Nematode Genomes initiative?",
        "answer": "The 959 Nematode Genomes initiative is a collaborative scientific project aimed at sequencing and analyzing the genomes of 959 different species of nematodes (roundworms). Nematodes are a large and diverse group of organisms that play important roles in various ecosystems, including agriculture, medicine, and ecology. By studying the genomes of these nematode species, researchers hope to gain insights into their biology, evolution, host-parasite interactions, and potential applications in areas such as agriculture, drug discovery, and understanding human diseases. The project involves a global network of scientists working together to generate, analyze, and share genomic data on these nematode species.",
        "judge": 1
    },
    {
        "question": "What is the role of the Hof1-Cyk3 interaction in yeast?",
        "answer": "The Hof1-Cyk3 interaction plays a crucial role in cytokinesis, the process of cell division, in yeast. \nHof1 (Homologue of Fifteen) and Cyk3 (Cytokinesis protein 3) are two proteins that interact with each other during the final stages of cytokinesis. This interaction is necessary for proper actomyosin ring contraction and septum formation, which are essential steps in completing cell division.\nDuring cytokinesis, the actomyosin ring, composed of actin and myosin filaments, constricts and forms a contractile ring at the division site. The Hof1-Cyk3 complex interacts with the actomyosin ring, recruiting additional proteins involved in septum formation and cell wall synthesis.\nSpecifically, the Hof1-Cyk3 complex helps to stabilize and maintain the actomyosin ring and promotes constriction by regulating the activity of myosin. It also recruits enzymes required for septum formation, such as chitin synthase, to the division site. The septum is a structure that forms between the two daughter cells during cytokinesis and eventually becomes the cell wall.\nOverall, the interaction between Hof1 and Cyk3 is necessary for proper actomyosin ring contraction, septum formation, and completion of cytokinesis in yeast.",
        "judge": 1
    },
    {
        "question": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
        "answer": "In the case of the LiPS-A3S line, transgenes are inserted into chromosome 19.",
        "judge": 1
    },
    {
        "question": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
        "answer": "One popular R package for analyzing Non-invasive prenatal testing (NIPT) data is called \"nonnest2\". It is a versatile software package that offers various statistical methods for analyzing NIPT data, including estimating fetal fraction, detecting aneuploidies (such as Down syndrome), and identifying copy number variations. The nonnest2 package provides users with visualization tools and statistical tests to assess the performance of NIPT assays, as well as tools for data preprocessing and quality control.",
        "judge": 1
    },
    {
        "question": "Why should I trust investment banks' ratings?",
        "answer": "While investment banks' ratings can play a crucial role in investors' decision-making processes, it is important to approach them with some degree of skepticism. Here are a few reasons why you should consider other factors as well and exercise caution when relying solely on investment banks' ratings:\n1. Conflict of interest: Investment banks often have close relationships with the companies they cover. They may provide various services to these companies, such as investment banking and advisory services. This can potentially create conflicts of interest as it may influence their ratings, leading to biased assessments.\n2. Financial incentives: Ratings can impact a company's reputation and stock prices. Investment banks' analysts are often compensated based on their ratings' accuracy and their ability to generate business for the bank. This financial motivation may influence the objectivity of their assessments.\n3. Limited track record: Investment banks' ratings are derived from their research and analysis, but these ratings can change over time. It is essential to consider the track record of an analyst or a bank before placing complete trust in their ratings.\n4. Time lag: Rating changes by investment banks sometimes reflect information that is already known or reflected in the market. If you rely solely on these ratings, you might miss out on more up-to-date and relevant data.\n5. Alternative perspectives: Relying solely on one source for ratings limits your exposure to alternative viewpoints. It is advisable to consider ratings from multiple sources, such as independent research firms or credit rating agencies, to get a more comprehensive view.\nWhile investment banks' ratings can offer insights and a starting point for investment decisions, it is important to supplement them with your own research, diversify your sources, understand potential biases or conflicts, and consider other relevant factors before making any investment choices.",
        "judge": 0
    },
    {
        "question": "Are there graph kernel libraries available implemented in JAVA?",
        "answer": "Yes, there are several graph kernel libraries implemented in Java. Some of the popular ones are:\n1. Kernels4J: This is an open-source library that provides various graph kernel algorithms and implementations, including the classic random walk kernel and subtree kernel. It offers an easy-to-use API for computing and comparing graph kernels in Java.\n2. GraphKernels: This library provides a set of graph kernel algorithms and implements them using efficient data structures and algorithms for graph processing. It supports various types of kernels, including graphlet kernels, shortest-path kernels, and Weisfeiler-Lehman kernels.\n3. GEDLIB: GEDLIB is a Java library specifically designed for graph edit distance calculation. It provides graph similarity measures based on graph edit distance algorithms and offers graph kernel-based similarity measures as well.\n4. MLlib: Apache Spark's MLlib library includes several graph algorithms and utilities that can be used for analyzing large-scale graphs. Although it is primarily focused on distributed computing, it provides various graph processing and mining functionalities, including graph kernel computation.\nThese libraries offer different types of graph kernels and functionalities, so you can choose the one that best suits your requirements.",
        "judge": 1
    },
    {
        "question": "Which tool exist for predicting drug synergy with deep learning?",
        "answer": "There are several tools available for predicting drug synergy using deep learning techniques. Some of them include:\n1. DeepSynergy: It is a deep learning-based tool that predicts drug synergy by using convolutional neural networks (CNNs) and recurrent neural networks (RNNs). It uses molecular descriptors and drug-target interactions as input to predict drug synergy.\n2. DeepSynergyNet: This tool utilizes deep neural networks and graph convolutional networks (GCNs) to predict drug-drug synergy. It considers both chemical structures and gene expression data to make predictions.\n3. DeepSynth: DeepSynth is a deep learning-based method that uses graph convolutional neural networks (GCNs) to predict drug synergy based on chemical structures. It takes molecular fingerprints as input and predicts the probability of drug synergy.\n4. GIN-NNT: GIN-NNT (Graph Isomorphism Network-based Neural Network Toolkit) is a deep learning framework specifically designed for predicting drug synergy. It employs graph neural networks (GNNs) to learn from the molecular graph representation of drugs and predict synergy.\n5. DeeSyGNA: This tool uses deep learning to predict drug synergy in the context of gene expression data. It employs deep neural networks to integrate multiple data sources, including gene expression profiles and drug molecular structures, for accurate synergy prediction.\nIt is important to note that these tools may have different capabilities, input requirements, and performance levels. Researchers should carefully evaluate and choose the tool that best suits their specific needs and data types.",
        "judge": 1
    },
    {
        "question": "Through which protein interaction does MLP regulate F-actin dynamics?",
        "answer": "Myosin-like protein (MLP) primarily regulates F-actin dynamics through its interaction with actin-binding proteins such as tropomyosin (Tpm) and caldesmon (CaD). These interactions help modulate the assembly and disassembly of F-actin filaments, thereby regulating various cellular processes such as cell migration, cytokinesis, and muscle contraction. MLP's interaction with Tpm stabilizes actin bundles, while its interaction with CaD promotes actin depolymerization, leading to the regulation of F-actin dynamics.",
        "judge": 1
    },
    {
        "question": "What are manifestations of the Saint's Triad?",
        "answer": "The Saint's Triad is a concept derived from Christian theology that refers to the threefold expressions of holiness or sanctity. These manifestations or aspects of the Saint's Triad are:\n1. Purity: This aspect of the Saint's Triad relates to the idea of moral and spiritual purity. It implies living a life that is free from sin and corruption, striving to be pure in thoughts, actions, and intentions. Purity is often associated with traits like honesty, integrity, chastity, and innocence.\n2. Humility: Humility is another manifestation of the Saint's Triad and refers to a modest and unassuming approach to life. It involves recognizing one's limitations, weaknesses, and faults, and not seeking personal glory or recognition. Humility emphasizes selflessness, service to others, and a willingness to learn and grow.\n3. Charity: Charity, also known as love in Christian theology, is the third aspect of the Saint's Triad. It encompasses not only acts of kindness and generosity but also an unconditional love for all beings. Charity involves self-sacrifice, compassion, forgiveness, and a desire to help others in need. It is considered the supreme virtue and the fulfillment of all other commandments in Christianity.\nThese manifestations of the Saint's Triad are interconnected and often seen as interdependent, with each aspect supporting and enhancing the others. Together, they represent a comprehensive model of holiness and are considered essential qualities for individuals striving for spiritual growth and moral integrity in their Christian faith.",
        "judge": 1
    },
    {
        "question": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
        "answer": "In the species Saccharomyces cerevisiae (S. cerevisiae), also known as baker's yeast, an ancient whole genome duplication (WGD) event is widely accepted to have occurred. This event is estimated to have happened approximately 100 million years ago. \nAs a result of this ancient WGD, the genome of S. cerevisiae contains numerous duplicated genes. Genome sequencing and analysis have revealed that approximately 90% of the genes in S. cerevisiae are the result of this WGD. This translates to around 5,800 genes out of the approximately 6,500 genes of S. cerevisiae being duplicated during this event.",
        "judge": 1
    },
    {
        "question": "What is the HPG pore?",
        "answer": "The HPG pore refers to the High-Pressure Gas (HPG) Pore. It is a device used in scientific research to study the behavior of fluids and gases within porous materials under high-pressure conditions. The HPG pore can simulate and replicate the physical and chemical processes occurring in subsurface reservoirs, such as oil and gas formations, to better understand fluid flow, transport, and storage capacity within these porous materials. It helps scientists and engineers study various phenomena related to fluid behavior, including capillary pressure, relative permeability, and fluid-rock interactions. Ultimately, the HPG pore aids in the development and optimization of technologies and strategies for enhanced oil recovery, carbon sequestration, and other applications involving subsurface reservoirs.",
        "judge": 1
    },
    {
        "question": "Which Indian Prime Minister caused a personnel change in the Nanavati-Mehta Commission due to closeness with a member?",
        "answer": "The Indian Prime Minister who caused a personnel change in the Nanavati-Mehta Commission due to closeness with a member was Prime Minister Manmohan Singh.",
        "judge": 0
    },
    {
        "question": "How are SAHFS created?",
        "answer": "SAHFs (Sequential Attestation Hints Files) are created during the boot process of the operating system on an Intel-based computer system with a Trusted Platform Module (TPM) installed. Here is a general overview of how SAHFs are created:\n1. Boot Process: The process begins when the computer is powered on or restarted. During the boot process, the system firmware (e.g., BIOS, UEFI) initializes the hardware components.\n2. TPM Initialization: If a TPM is present, the system firmware initializes and configures the TPM. The TPM is a dedicated chip on the motherboard that stores cryptographic keys, securely measures the components of the system, and performs cryptographic operations.\n3. Measurement: As the boot process continues, the system firmware measures the integrity of various components of the system, such as the firmware code, bootloader, kernel, and other critical components. The measurements are usually performed using cryptographic hash functions.\n4. Attestation: Once the measurements are collected, the system firmware generates an attestation for this bundle of measurements using the private key of the TPM. The attestation is a cryptographic proof that the measurements were taken and signed by a valid TPM.\n5. SAHF Creation: The attestation generated in the previous step forms the basis for creating the SAHF. The SAHF is a digitally signed file that contains the measurements and the attestation information. It is usually created by the firmware or an operating system component.\n6. Persistence: The SAHF is securely stored in a specific location on the system, typically within the TPM. This ensures that the SAHF remains protected and tamper-resistant.\nSAHFs are primarily used in the context of trusted boot mechanisms to verify the integrity of the system's boot chain, making them an essential component of securing the system's boot process.",
        "judge": 1
    },
    {
        "question": "How does the bank/IRS know whether a bank transfer over $14k is a gift or loan repayment?",
        "answer": "When a bank transfer of over $14k occurs, the bank is required by law to report the transaction to the Internal Revenue Service (IRS). However, it is important to note that this reporting threshold may change, so it's essential to stay updated with current regulations.\nWhen the bank reports the transaction to the IRS, they do not specifically determine whether it is a gift or loan repayment. Instead, it is the responsibility of the individuals involved in the transaction to accurately report it on their tax returns and provide proper documentation supporting the purpose of the transfer.\nIf the transfer is considered a gift, the person making the gift may need to file a gift tax return (Form 709) with the IRS, depending on the total amount of the gifts made during the year. Currently, an individual can gift up to $15k per recipient per year without triggering any gift tax requirements.\nIn the case of a loan repayment, proper documentation such as a signed loan agreement, regular repayment schedules, and proof of the lender's intent to collect the loan is crucial. This information can help establish that the transfer was a legitimate loan repayment rather than a taxable gift.\nUltimately, it is the responsibility of the individuals involved to report and document the details of the transaction correctly. If there are any concerns or uncertainties regarding the classification of the transfer, consulting an experienced tax professional or accountant is advisable.",
        "judge": 0
    },
    {
        "question": "Is there a vaccine for peanut allergy?",
        "answer": "As of now, there is no approved vaccine available for peanut allergy. However, there have been ongoing research and clinical trials exploring the development of a peanut allergy vaccine. These vaccine candidates aim to desensitize individuals to peanut allergens by gradually exposing them to increasing doses of peanut proteins. It is important to note that these vaccines are still in the experimental stages, and further studies are required to evaluate their effectiveness and safety. If you or someone you know has a peanut allergy, it is crucial to consult with a healthcare professional for appropriate management strategies.",
        "judge": 1
    },
    {
        "question": "Which algorithm is used for detection of long repeat expansions?",
        "answer": "One algorithm commonly used for the detection of long repeat expansions is Repeat Finder. Repeat Finder is an algorithm specifically designed to identify long repeat expansions in genomic sequences. It utilizes a combination of suffix tree and pattern matching algorithms to efficiently detect and classify repeat expansions. Another popular algorithm used for this purpose is Tandem Repeats Finder (TRF), which employs a statistical method to detect tandem repeats in DNA sequences. Both algorithms have been extensively used in genomics research to identify and analyze repeat expansions associated with genetic disorders.",
        "judge": 1
    },
    {
        "question": "Which programming language has been used for implementing GWAR?",
        "answer": "The GWAR (Generalized Word Alignment Repository) tool was implemented using the Python programming language.",
        "judge": 1
    },
    {
        "question": "What is the TALE-iD method used for?",
        "answer": "The TALE-iD method is used for talent identification in sports. It is a systematic process that assists in identifying individuals who have the potential to excel in a specific sport or athletic activity. The method combines various assessments and evaluations, including physical, technical, tactical, and psychological factors, to determine an individual's talent and potential for future success in their chosen sport.",
        "judge": 1
    },
    {
        "question": "What type of topoisomerase inhibitor is gepotidacin?",
        "answer": "Gepotidacin is a bacterial topoisomerase inhibitor. Specifically, it is an inhibitor of topoisomerase II.",
        "judge": 1
    },
    {
        "question": "Which Lisp framework has been developed for image processing?",
        "answer": "One Lisp framework that has been developed for image processing is the Common Lisp-based framework called \"CL-IMAGE\". CL-IMAGE provides functionalities for basic image manipulation such as loading, saving, resizing, cropping, and transforming images. It also supports various image file formats including BMP, PNG, JPEG, and TIFF.",
        "judge": 1
    },
    {
        "question": "Which brain tumors does neuroligin-3 promote?",
        "answer": "Neuroligin-3 is a protein that plays a role in synaptic function and has been found to be overexpressed in several types of brain tumors. These include glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer, as well as medulloblastoma and high-grade gliomas. Neuroligin-3 promotes tumor growth and invasion in these brain tumors and is associated with poorer prognosis.",
        "judge": 1
    },
    {
        "question": "List STING agonists.",
        "answer": "1. LPS (lipopolysaccharide)\n2. Poly(I:C) (polyinosinic:polycytidylic acid)\n3. Imiquimod\n4. CpG (CpG oligodeoxynucleotides)\n5. Resiquimod\n6. R848\n7. Flagellin\n8. Muramyl dipeptide\n9. Pam3CSK4\n10. Zymosan",
        "judge": 1
    },
    {
        "question": "Are mouse chromosomes acrocentric?",
        "answer": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes have a centromere located near one end, resulting in a very short \"p arm\" (the shorter arm of the chromosome). Mouse chromosomes, like most mammalian chromosomes, are metacentric or submetacentric, which means that the centromere is located towards the center of the chromosome, resulting in the two arms being relatively similar in length.",
        "judge": 1
    },
    {
        "question": "Which disorders are caused by de novo mutations in ZSWIM6?",
        "answer": "At present, there are no known disorders that are specifically caused by de novo mutations in the ZSWIM6 gene. ZSWIM6 is a protein-coding gene that is involved in various biological processes. While de novo mutations in the ZSWIM6 gene may exist, there is limited information available regarding their specific phenotypic effects. Further research is needed to understand the potential association between de novo mutations in ZSWIM6 and specific disorders or clinical conditions.",
        "judge": 1
    }
]